Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online March 14, 2007
Diabetes Care 30:1647-1652, 2007
DOI: 10.2337/dc07-9921
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc07-9921v1
dc07-9921v2
30/6/1647    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klein, S.
Right arrow Articles by Kahn, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klein, S.
Right arrow Articles by Kahn, R.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Reviews/Commentaries/ADA Statements
Consensus Statement

Waist Circumference and Cardiometabolic Risk

A Consensus Statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association

Samuel Klein, MD1, David B. Allison, PHD2, Steven B. Heymsfield, MD3, David E. Kelley, MD4, Rudolph L. Leibel, MD5, Cathy Nonas, MS, RD, CDE6 and Richard Kahn, PHD7

1 Division of Geriatrics and Nutritional Science, Center for Human Nutrition, Washington University School of Medicine, St. Louis, Missouri
2 Clinical Nutrition Research Unit, University of Alabama at Birmingham, Birmingham, Alabama
3 Clinical Research Department, Metabolism, Merck Pharmaceutical Company, Rahway, New Jersey
4 Obesity and Nutrition Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania
5 Naomi Berrie Diabetes Center, Columbia University, New York, New York
6 Obesity and Diabetes Programs, North General Hospital, New York, New York
7 American Diabetes Association, Alexandria, Virginia

Address correspondence and reprint requests to Samuel Klein, MD, Washington University School of Medicine, 660 South Euclid Ave., Campus Box 8031, St. Louis, MO 63110. E-mail: sklein@wustl.edu

Abbreviations: CHD, coronary heart disease • CT, computed tomography • IAAT, intra-abdominal adipose tissue • MRI, magnetic resonance imaging • NHANES III, National Health and Nutrition Examination Survey III • SAAT, subcutaneous abdominal adipose tissue • WC, waist circumference • WHO, World Health Organization

The first 300 words of the full text of this article appear below.


    INTRODUCTION
 
Obesity is an important risk factor for cardiometabolic diseases, including diabetes, hypertension, dyslipidemia, and coronary heart disease (CHD). Several leading national and international institutions, including the World Health Organization (WHO) and the National Institutes of Health, have provided guidelines for classifying weight status based on BMI (1,2). Data from epidemiological studies demonstrate a direct correlation between BMI and the risk of medical complications and mortality rate (e.g., 3,4). Men and women who have a BMI ≥30 kg/m2 are considered obese and are generally at higher risk for adverse health events than are those who are considered overweight (BMI between 25.0 and 29.9 kg/m2) or lean (BMI between 18.5 and 24.9 kg/m2). Therefore, BMI has become the "gold standard" for identifying patients at increased risk for adiposity-related adverse health outcomes.

Body fat distribution is also an important risk factor for obesity-related diseases. Excess abdominal fat (also known as central or upper-body fat) is associated with an increased risk of cardiometabolic disease. However, precise measurement of abdominal fat content requires the use of expensive radiological imaging techniques. Therefore, waist circumference (WC) is often used as a surrogate marker of abdominal fat mass, because WC correlates with abdominal fat mass (subcutaneous and intra-abdominal) (5) and is associated with cardiometabolic disease risk (6). Men and women who have waist circumferences greater than 40 inches (102 cm) and 35 inches (88 cm), respectively, are considered to be at increased risk for cardiometabolic disease (7). These cut points were derived from a regression curve that identified the waist circumference values associated with a BMI ≥30 kg/m2 in primarily Caucasian men and women living in north Glasgow (8).

An expert panel, organized by the National Heart, Lung and Blood Institute, . . . [Full Text of this Article]


    QUESTION 1: What does waist circumference measure?
 
Measurement technique.
Anatomical relationships.

    QUESTION 2: What are the biological mechanisms responsible for the association between waist circumference and metabolic and cardiometabolic risk?
 

    QUESTION 3: What is the power of waist circumference to predict adverse cardiometabolic outcomes? How does the predictive power of waist circumference compare with that of BMI? Does waist circumference measurement in addition to BMI improve predictability?
 

    QUESTION 4: Should waist circumference be measured in clinical practice?
 

    CONCLUSIONS
 

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
GutHome page
M Manco, G Bedogni, M Marcellini, R Devito, P Ciampalini, M R Sartorelli, D Comparcola, F Piemonte, and V Nobili
Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis
Gut, September 1, 2008; 57(9): 1283 - 1287.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
R. Ness-Abramof and C. M. Apovian
Waist Circumference Measurement in Clinical Practice
Nutr Clin Pract, August 1, 2008; 23(4): 397 - 404.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. Koster, M. F. Leitzmann, A. Schatzkin, T. Mouw, K. F. Adams, J. Th. M. van Eijk, A. R. Hollenbeck, and T. B. Harris
Waist Circumference and Mortality
Am. J. Epidemiol., June 15, 2008; 167(12): 1465 - 1475.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
P. M. Janiszewski, I. Janssen, and R. Ross
Does Waist Circumference Predict Diabetes and Cardiovascular Disease Beyond Commonly Evaluated Cardiometabolic Risk Factors?
Diabetes Care, December 1, 2007; 30(12): 3105 - 3109.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.